Systagenix Wound Management, a new portfolio company created by One Equity Partners, has recently been launched with the intent of establishing a new global force in advanced wound care, and committed to providing innovative products that help enhance patients’ quality of life.
Systagenix Wound Management, formerly the Professional Wound Care Business of Ethicon Inc, a Johnson & Johnson company, will be headquartered in the UK and aims to make the company a leading global provider of innovative wound care solutions, meeting the demands and needs of its customers to improve and transform the lives of patients.
Steve Atkinson, CEO of Systagenix, commented, “We are totally focused on making Systagenix Wound Management the strongest and most admired wound care company.”
Executive Chairman, Chris Fashek added: “We are committed to making Systagenix an outstanding success, focusing on patient needs and working with clinicians as partners to provide enhanced wound care solutions. Systagenix Wound Management may be a new name, but our people remain committed to the core value of providing advanced therapies that will improve the lives of patients. “
